These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30298378)

  • 21. Aspects of the radioiodine treatment of thyroid carcinoma.
    HALNAN KE; POCHIN EE
    Metabolism; 1957 Jan; 6(1):49-62. PubMed ID: 13386968
    [No Abstract]   [Full Text] [Related]  

  • 22. [Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer].
    Im M; Lee JK; Hong YJ; Hong SI; Kang HJ; Na II; Ryoo BY; Cheon GJ; Lee HN; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):425-9. PubMed ID: 19127106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid carcinoma; a report on the diagnostic and therapeutic use of radio-iodine.
    KRAMER S; CONCANNON JP; EVANS HD; CLARK GM
    Br J Radiol; 1955 Jun; 28(330):307-13. PubMed ID: 14378543
    [No Abstract]   [Full Text] [Related]  

  • 24. Thyroid carcinoma treated with radioactive iodine; an eight-year experience.
    BEIERWALTES WH; JOHNSON PC
    J Mich State Med Soc; 1956 Apr; 55(4):410-9. PubMed ID: 13307215
    [No Abstract]   [Full Text] [Related]  

  • 25. An evaluation of various factors influencing the treatment of metastatic thyroid carcinoma with I 131.
    MALOOF F; VICKERY AL; RAPP B
    J Clin Endocrinol Metab; 1956 Jan; 16(1):1-27. PubMed ID: 13278379
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma.
    Fard-Esfahani A; Emami-Ardekani A; Fallahi B; Fard-Esfahani P; Beiki D; Hassanzadeh-Rad A; Eftekhari M
    Nucl Med Commun; 2014 Aug; 35(8):808-17. PubMed ID: 24751702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.
    Patel SS; Goldfarb M
    J Surg Oncol; 2013 May; 107(6):665-72. PubMed ID: 23192391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma of the thyroid; treatment with iodine.
    ALLEN WE
    J Natl Med Assoc; 1958 Jan; 50(1):40-2. PubMed ID: 13492026
    [No Abstract]   [Full Text] [Related]  

  • 29. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 30. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.
    Clement SC; Peeters RP; Ronckers CM; Links TP; van den Heuvel-Eibrink MM; Nieveen van Dijkum EJ; van Rijn RR; van der Pal HJ; Neggers SJ; Kremer LC; van Eck-Smit BL; van Santen HM
    Cancer Treat Rev; 2015 Dec; 41(10):925-34. PubMed ID: 26421813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioactive iodine in the treatment of carcinoma of the thyroid.
    ABOU-SINNA IA
    J Egypt Med Assoc; 1959; 42():97-102. PubMed ID: 13791511
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
    Gandhi S; Abhyankar A; Basu S
    Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematological changes secondary to treatment of thyroid cancers by strong doses of radioactive iodine].
    COLIEZ R; TUBIANA M; MABILLE JP
    J Radiol Electrol Arch Electr Medicale; 1959; 40(1-2):76-83. PubMed ID: 13642360
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioiodine therapy: its role in the combined treatment of differentiated thyroid carcinoma.
    Jarzab B; Włoch J
    Przegl Lek; 2000; 57 Suppl 5():108-9. PubMed ID: 11202268
    [No Abstract]   [Full Text] [Related]  

  • 35. Four cases illustrating the use of I 131 in the management of metastatic carcinoma of the thyroid.
    STORAASLI JP; KING DP
    Am J Roentgenol Radium Ther Nucl Med; 1956 Jun; 75(6):1150-61. PubMed ID: 13313885
    [No Abstract]   [Full Text] [Related]  

  • 36. The fractionation of urinary iodine. 2. Metabolites excreted during treatment of carcinoma of the thyroid.
    FLETCHER K
    Biochem J; 1957 Sep; 67(1):140-6. PubMed ID: 13471524
    [No Abstract]   [Full Text] [Related]  

  • 37. The study and treatment of 119 cases of carcinoma of the thyroid with radioactive iodine.
    DOBYNS BM; MALOOF F
    J Clin Endocrinol Metab; 1951 Nov; 11(11):1323-60. PubMed ID: 14880610
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer.
    Van Nostrand D
    Endocrinol Metab Clin North Am; 2017 Sep; 46(3):783-793. PubMed ID: 28760238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of carcinoma of the thyroid.
    MACK RE; OGBORN RE; WELLS HJ
    J Am Med Assoc; 1957 Jan; 163(1):15-20. PubMed ID: 13376335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.